We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not sep ...
Beximco Pharmaceuticals Ltd 30 April 2024 30 April 2024 BEXIMCO PHARMACEUTICALS LIMITED Q3 Financial Results Beximco Pharmaceuticals Limited ("Beximco Pharma", "BPL" or "the Company";...
ticals Ltd - generic pharmaceutical products and active ingredients' manufacturer - Announces that Non-Executive Direc ...
Beximco Pharmaceuticals Ltd 04 March 2024 4 March 2024 BEXIMCO PHARMACEUTICALS LIMITED Appointment of Managing Director Beximco Pharmaceuticals Limited ("Beximco Pharma", "BPL" or "the...
Beximco Pharmaceuticals Ltd on Tuesday said it aimed to continue momentum into the second half as it reported profit ...
Beximco Pharmaceuticals Ltd 30 January 2024 30 January 2024 This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation 596/2014 which...
Beximco Pharmaceuticals Ltd 25 January 2024 25 January 2024 BEXIMCO PHARMACEUTICALS LIMITED Payment of Cash Dividend Beximco Pharmaceuticals Limited ("Beximco Pharma", "BPL" or "the...
ticals Ltd - generic pharmaceutical products and active ingredients' manufacturer - Says Managing Director Nazmul Hass ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions